Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Kissei Pharmaceutical Co ( (JP:4547) ) has issued an update.
Kissei Pharmaceutical Co., Ltd. has completed the sale of two listed stocks, resulting in a gain of ¥11,605 million. This transaction is part of the company’s strategy to enhance medium- to long-term capital returns by reallocating funds to growth investments, particularly in R&D, without affecting its current earnings forecast.
The most recent analyst rating on (JP:4547) stock is a Buy with a Yen4943.00 price target. To see the full list of analyst forecasts on Kissei Pharmaceutical Co stock, see the JP:4547 Stock Forecast page.
More about Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and sale of pharmaceutical products. The company is committed to improving capital efficiency and enhancing shareholder value through strategic investments in research and development.
Average Trading Volume: 79,672
Technical Sentiment Signal: Buy
Current Market Cap: Yen180.5B
For detailed information about 4547 stock, go to TipRanks’ Stock Analysis page.